Advertisement
Canada markets close in 5 hours 6 minutes
  • S&P/TSX

    21,909.77
    -206.92 (-0.94%)
     
  • S&P 500

    5,274.19
    -9.21 (-0.17%)
     
  • DOW

    38,602.84
    +31.81 (+0.08%)
     
  • CAD/USD

    0.7309
    -0.0031 (-0.42%)
     
  • CRUDE OIL

    73.02
    -1.20 (-1.62%)
     
  • Bitcoin CAD

    95,302.70
    +820.45 (+0.87%)
     
  • CMC Crypto 200

    1,452.48
    +5.33 (+0.37%)
     
  • GOLD FUTURES

    2,340.40
    -28.90 (-1.22%)
     
  • RUSSELL 2000

    2,041.80
    -17.89 (-0.87%)
     
  • 10-Yr Bond

    4.3570
    -0.0450 (-1.02%)
     
  • NASDAQ

    16,794.45
    -34.22 (-0.20%)
     
  • VOLATILITY

    13.57
    +0.46 (+3.51%)
     
  • FTSE

    8,232.28
    -30.47 (-0.37%)
     
  • NIKKEI 225

    38,837.46
    -85.54 (-0.22%)
     
  • CAD/EUR

    0.6714
    -0.0013 (-0.19%)
     

Theratechnologies Reports on its Annual Meeting of Shareholders

Theratechnologies
Theratechnologies

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.

Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:

 

FOR

% FOR

ABSTENTION

% ABSTENTION

Joseph Arena

22,405,047

 

93.09

%

1,663,754

 

6.91

%

Frank Holler

21,008,601

 

87.29

%

3,060,200

 

12.71

%

Paul Lévesque

20,966,427

 

87.11

%

3,102,374

 

12.89

%

Andrew Molson

21,067,050

 

87.53

%

3,001,751

 

12.47

%

Dawn Svoronos

20,964,213

 

87.10

%

3,104,588

 

2.90

%

Elina Tea

21,734,254

 

90.30

%

2,334,547

 

9.70

%

Dale Weil

21,009,681

 

87.29

%

3,059,120

 

12.71

%

Jordan Zwick

23,107,383

 

96.01

%

961,418

 

3.99

%

Frank Holler will now act as Chair of the Board of Directors of the Company.

ADVERTISEMENT

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800